Abstract
BACKGROUND: Pharmacists are increasingly acknowledging their responsibility to inform and counsel patients. However, it is unclear how these tasks are implemented and whether patients' needs are being fulfilled. OBJECTIVE: To examine patients' perceptions of information received at the start of selective serotonin-reuptake inhibitor (SSRI) treatment, aiming to identify (1) information needs and (2) the potential role of the community pharmacist as information provider. METHODS: A qualitative descriptive study comprising semi-structured telephone interviews was carried out with patients who had recently started a new course of SSRI treatment. Patients were recruited through 6 Dutch community pharmacies. The interviews were guided by the following topics: type of information obtained, unmet information needs, preferred information provider, and the role of the pharmacist. RESULTS: Forty-one patients took part in an interview. Information needs varied widely among patients; overall, patients felt that they would benefit from information tailored to their needs. Many patients required more concrete and practical information on adverse effects and delayed onset of action than was provided. In addition, an explanation of the term dependency in the context of SSRI use and a discussion of the necessity for use and believed harms of long-term treatment were important to patients. Regardless of patients' needs, the role of the pharmacist was generally perceived as limited, and patients identified several pharmacy-related barriers to improved communication, including the timing of information (mainly restricted to first-time dispensing), lack of time and privacy, lack of empathy and a protocol-driven way of providing information, and inexperience of pharmacy technicians. CONCLUSIONS: Patients starting treatment with antidepressants may benefit from information tailored to their personal needs. Along with the prescribing physician, community pharmacists could have an important role in informing and counseling patients.
| Original language | English |
|---|---|
| Pages (from-to) | 642-649 |
| Number of pages | 8 |
| Journal | Annals of Pharmacotherapy |
| Volume | 43 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1 Apr 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Counseling
- Education
- Pharmacy
- Selective serotonin-reuptake inhibitors
- citalopram
- escitalopram
- fluoxetine
- fluvoxamine
- paroxetine
- serotonin uptake inhibitor
- sertraline
- adult
- anxiety disorder
- article
- counseling
- depression
- drug induced disease
- drug information
- drug mechanism
- drug surveillance program
- drug use
- drug withdrawal
- female
- health care need
- health education
- human
- interview
- long term care
- major clinical study
- male
- medical information
- medical practice
- mood disorder
- obsessive compulsive disorder
- panic
- patient attitude
- perception
- pharmacist
- pharmacy
- practice guideline
- priority journal
Fingerprint
Dive into the research topics of 'Patients' perceptions of information received at the start of selective serotonin-reuptake inhibitor treatment: Implications for community pharmacy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver